Supplementary Figure S8 -Photographs of tissue punches and retrieved alginate spheres from the subcutaneous space of non-human primates (NHPs). Supplementary Figure S9 -Laparoscopic imaging during multiple minimally invasive procedures (one implantation at day 0 and one retrieval at 2 weeks post-implant) for analysis of medium and large SLG20 spheres delivered into the intraperitoneal space of non-human (cynomolgus macaque) monkeys. Supplementary Figure 
Materials and Methods

a. Materials/Reagents
All chemicals were obtained from Sigma-Aldrich (St. Louis, MO) and cell culture reagents from Life Technologies (Grand Island, NY), unless otherwise noted. Antibodies: Alexa Fluor 488-conjugated anti-mouse CD68 (Cat. #137012, Clone FA-11) and Alexa Fluor 647-conjugated anti-mouse Ly-6G/Ly-6C (Gr-1) (Cat. #137012, Clone RB6-8C5) were purchased from BioLegend Inc. (San Diego, CA). Alexa Fluor 647-conjugated anti-mouse TGF beta1 (Cat. #bs-0103R-A647) was purchased from Bioss antibodies. Cy3-conjugated anti-mouse alpha smooth muscle actin antibody was purchased from Sigma Aldrich (St. Louis MO). Filamentous actin (Factin)-specific Alexa Fluor 488-conjugated Phalloidin, and Newport Green were purchased from Life Technologies (Grand Island, NY) . Glass spheres of medium (500 µm) and large size (2 mm) where purchased from Sigma Aldrich (St. Louis, MO). Stainless steel spheres of medium (500µm) and large (2.5mm) size were purchased from Thomas Scientific (Swedesboro, NJ).
Polystyrene spheres of medium (400-500 µm) and large (2 mm) size where purchased from Phosphorex (Hopkinton, MA). A sampling of spheres used in study were submitted for endotoxin testing by a commercial vendor (Charles River, Wilmington, MA) and the results showed that spheres contained < 0.05 EU/ml of endotoxin levels.
b. Fabrication of alginate hydrogel spheres
Alginate hydrogel spheres were made using a custom-built, electro-jetting device, consisting of a voltage generator, a vertical syringe pump, and a grounded autoclavable glass collector. The voltage was coupled to the syringe and needle containing the alginate solution while the gelling bath was grounded to complete the circuit. Spheres were generated using a 1.4% solution of a commercially available alginate (PRONOVA SLG20 (endotoxin levels or LF10/60 NovaMatrix, Sandvika, Norway) dissolved in 0.9% saline (pH ≈ 7.4, Osmotic pressure ≈ 290 mOsm), and crosslinked using a BaCl 2 gelling solution (20mM BaCl 2 , 250mM D-Mannitol, 25mM HEPES, pH ≈ 7.4, Osmotic pressure ≈ 290 mOsm) 1 .
Alginate hydrogel microspheres of varying sizes were generated by utilizing different needle gauges, voltages, and flow rates; 0.3 mm spheres were generated using a 30G blunt needle, a voltage of 5kV, and a 200 µl/min flow rate, 0.4 mm spheres were generated with a 25G blunt needle, a voltage of 7kV and a 200 µl/min flow rate, 0.5 mm spheres were generated with a 25G blunt needle, a voltage of 5kV and a 200 µl/min flow rate, 0.7 mm spheres were generated with a 25G blunt needle, a voltage of 4kV and a 180 µl/min flow rate, 0.9 mm spheres were generated with an 18G blunt needle, a voltage of 7kV and a 200 µl/min flow rate, 1 mm spheres were generated with an 18G blunt needle, a voltage of 6kV and a 200 µl/min flow rate, 1.5 mm spheres were generated with an 18G blunt needle, a voltage of 5kV and a 180 µl/min flow rate, and 1.9 mm spheres were generated with an 18G blunt needle with a voltage of 5 kV and a 150 µl/min flow rate. All microspheres were cross-linked in 250 mL of BaCl 2 -gelling solution in a sterile glass container. Immediately after crosslinking, the spheres were washed with HEPES buffer (25mM HEPES, 1.2mM MgCl 2 ×6H2O, 4.7mM KCl, 132mM NaCl 2 , pH≈7.4, ≈290 mOsm) 4 times and stored overnight at 4°C. Immediately prior to implantation into the peritoneal cavity of mice, the spheres were washed an additional 2 times with 0.9% saline. A sampling of the fabricated hydrogels was submitted for endotoxin testing by a commercial vendor (Charles River, Wilmington, MA) and the results showed that LF10/60 spheres contained 31.6 EU/mL of endotoxins while SLG20 hydrogels contained < 0.05 EU/ml of endotoxin levels.
c. Polycaprolactone (PCL) sphere synthesis
Polycaprolactone (PCL, Mn 70,000-90,000, Sigma) microspheres were prepared by solvent evaporation with medium (0.3-0.5 mm) and large (1.5-2.0 mm) diameters. Small diameter microspheres were fabricated by dissolving PCL in dichloromethane (Fisher) at 6.5%
concentration. This solution was introduced drop-wise into a 1% polyvinylalcohol (PVA, 88 mol% hydrolyzed, Polysciences Inc.) solution stirred using a stainless steel 4-blade overhead impeller at 200 rpm. After 75 min, the dispersion was added to 400 mL of ddH 2 O and stirred for an additional 105 min until all of the solvent evaporated. The microspheres were then sieved, washed several times with water, flash frozen in liquid nitrogen and lyophilized overnight. Large microspheres were prepared similarly using 9% polymer concentration, 0.5% PVA solution, and a 3-blade overhead impeller stirred at 150 rpm.
d. Rat Islet Isolation, Purification, and Encapsulation
Male Sprague-Dawley rats from Jackson Laboratories (Bar Harbor, ME) weighing approximately 300 grams were used for harvesting islets. All rats were anesthetized by a 1:20 xylazine (10 mg/kg) to ketamine (150 mg/kg) injection given intraperitoneally, and the total volume of each injection was 0.4 ml -0.5 ml depending on the weight of rat. Isolation surgeries were performed as described by Lacy and Kostianovsky 2 . Briefly, the bile duct was cannulated and the pancreas was distended by an in vivo injection of 0.15% Liberase (Research Grade, Roche) in RPMI 1640 media solution. Rats were sacrificed by cutting the descending aorta and the distended pancreatic organs were removed and held in 50 ml conical tubes on ice until the completion of all surgeries. All tubes were placed in a 37°C water bath for a 30 min digestion, which was stopped by adding 10-15 ml of cold M199 media with 10% heat-inactivated fetal bovine serum (HIFBS) and lightly shaking. Digested pancreases were washed twice in the same aforementioned M199 media, filtered through a 450 µm sieve, and then suspended in a Histopaque 1077 (Sigma)/M199 media gradient and centrifuged at 1,700 RCF at 4°C. Depending on the thickness of the islet layer that was formed within the gradient, this step was repeated for higher purity islets. Finally, the islets were collected from the gradient and further isolated by a series of six gravity sedimentations, in which each supernatant was discarded after four minutes of settling. Purified islets were hand-counted by aliquot under a light microscope and then washed three times in sterile 1X phosphate-buffered saline. Islets were then washed once in RPMI 1640 media with 10% HIFBS and 1% penicillin/streptomycin, and cultured in this media overnight for further use.
Immediately prior to encapsulation, the cultured islets were centrifuged at 1,400 rpm for 1 Harbor, ME) were anesthetized with 3% isoflurane in oxygen and had their abdomens shaved and sterilized using betadine and isopropanol. Preoperatively, all mice also received a 0.05 mg/kg dose of buprenorphine subcutaneously as a pre-surgical analgesic, along with 0.3 mL of 0.9% saline subcutaneously to prevent dehydration. A 0.5 mm incision was made along the midline of the abdomen and the peritoneal lining was exposed using blunt dissection. The peritoneal wall was then grasped with forceps and a 0.5-1 mm incision was made along the linea alba. A desired volume of spheres (all materials without islets, as well as SLG20 spheres encapsulating rat islets) were then loaded into a sterile pipette and implanted into the peritoneal cavity through the incision. The incision was then closed using 5-0 taper-tipped polydioxanone (PDS II) absorbable sutures. The skin was then closed over the incision using a wound clip and tissue glue.
For non-human primate (NHP) procedures, buprenorphine (0.01-0.03 mg/kg) was administered as a pre-operative analgesic. NHPs were then sedated using an intramuscular (IM) injection of ketamine (10 mg/kg) with an addition of midazolam as dictated by DCM vet staff if needed for additional sedation. Animals were maintained on a circulating warm water blanket and covered with a towel during the procedure to maintain body temperature. Either 0.5 or 1.5 mm diameter SLG20 spheres were injected into the dorsal (back) regions of 4 non-human primates (cynomolgus macaques) using 18 and 12 gauge custom-manufactured (Harvard Apparatus) sterile stainless steel needles, with slip tip syringes in order to prevent shearing of our biomaterial upon injection. Needles were inserted tangentially to the backs of the NHPs, and were slid (tunneled) approximately 1-2 cm away from the initial injection point, in order to try to separate the injection from that of the site of eventual material response. Spheres (0.5 and 1.5 mm diameter) were injected into 4 total spots on the flank of 4 of our non-human primates: two spots on the left flank and two on the right, for 0.5 mm and 1.5 mm diameter sphere implants, respectively. Saline was injected and 4 mm diameter SLG20 alginate cylindrical discs were implanted by making a minimal 1 cm incision, also on the left and right sides of the back, respectively into 3 additional primates. Incisions were closed with either a single interrupted suture with 3-0 nylon or VetBond (tissue glue).
f. Blood glucose monitoring
To create insulin-dependent diabetic mice, healthy C57BL/6 mice were treated with Streptozotocin (STZ) by the vendor (Jackson Laboratory, Bar Harbor, ME) prior to shipment to MIT. The blood glucose levels of all the mice were retested prior to transplantation. Only mice whose non-fasted blood glucose levels were above 300 mg/dL for two consecutive days were considered diabetic and underwent transplantation.
Blood glucose levels were monitored three times a week following transplantation of isletcontaining alginate capsules. A small drop of blood was collected from the tail vein using a lancet and tested using a commercial glucometer (Clarity One, Clarity Diagnostic Test Group, Boca Raton, FL). Mice with unfasted blood glucose levels below 200mg/dL were considered normoglycemic. Monitoring continued until all mice had returned to a hyperglycemic state at which point they were euthanized and the spheres were retrieved.
g. Retrieval of cells, tissues, and materials
At desired time points post-implantation or transplantation (with encapsulated islets), as specified in figures, mice were euthanized by CO 2 administration, followed by cervical dislocation. In certain instances, 5 ml of ice cold PBS was first injected in order perform an intraperitoneal lavage to rinse out and collect free-floating intraperitoneal immune cells. An incision was then made using the forceps and scissors along the abdomen skin and peritoneal wall, and intraperitoneal lavage volumes were pipetted out into fresh 15 ml falcon tubes (each prepared with 5 ml of RPMI cell culture media). Next, a wash bottle tip was inserted into the abdominal cavity. KREBS buffer was then used to wash out all material spheres from the abdomen and into petri dishes for collection. After ensuring all the spheres were washed out or manually retrieved (if fibrosed directly to intraperitoneal tissues), they were transferred into 50 mL conical tubes for downstream processing and imaging. After intraperitoneal lavage and sphere retrieval, remaining fibrosed intraperitoneal tissues were also excised for downstream FACS and expression analyses.
For non-human primate subcutaneous retrievals, similar to when material was implanted, NHPs were once again given buprenorphine (0.01-0.03 mg/kg) as a pre-operative analgesic, and sedated using an IM injection of ketamine (10 mg/kg), with midazolam as dictated by DCM vet staff if needed for additional sedation. Animals were once again maintained on a circulating warm water blanket and covered with a towel during the procedure to maintain body temperature.
8 mm diameter biopsy punches were then used to sample the entire skin and subcutaneous space at 2 and later at 4 weeks post-implantation. Following biopsy punches, the retrieval site was closed with 3-0 nylon in a simple-interrupted pattern and VetBond (tissue glue).
h. Imaging of the retrieved material spheres
For phase contrast imaging retrieved materials were gently washed using Krebs buffer and transferred into 35 mm petri dishes for phase contrast microscopy using an Evos Xl microscope (Advanced Microscopy Group).
For bright-field imaging of retrieved materials, samples were gently washed using Krebs buffer and transferred into 35 mm petri dishes for bright-field imaging using a Leica Stereoscopic microscope.
i. Newport Green and Live/Dead Islet Staining
LIVE/DEAD® Viability/Cytotoxicity Kit (Life technologies, Carlsbad CA; CA# L-3224) was used according to the manufacturer's instructions to assess the viability of islets postencapsulation. Newport Green™ DCF Diacetate (Life technologies, Carlsbad CA; CA# N-7991), cell permeant dye combined with DAPI was used to stain encapsulated islet cells post-retrieval.
j. Confocal Immunofluorescence
Immunofluorescence imaging was used to determine immune populations attached to spheres.
Materials were retrieved from mice and fixed overnight using 4% paraformaldehyde at 4°C.
Samples where then washed twice with KREBS buffer, permeabilized for 30 min using a 0.1% Triton X100 solution, and subsequently blocked for 1 hour using a 1% bovine serum albumin (BSA) solution. Next, the spheres were incubated for 1 hour in an immunostaining cocktail solution consisting of DAPI (500 nM), specific marker probes ( 
k. Histological processing for H&E and Masson's Trichrome staining
Retrieved materials where fixed overnight using 4% paraformaldehyde at 4°C. After fixation, alginate sphere or retrieved tissue samples were washed using 70% alcohol. The materials where then mixed with 4 degrees calcium-cooled Histogel (VWR, CA # 60872-486). After the molds hardened, the blocks were processed for paraffin embedding, sectioning and staining according to standard histological methods.
l. Western Blotting
Protein was extracted directly from materials for western blot analysis. For protein analyses, retrieved materials were prepared by immersing materials in Pierce RIPA buffer (Cat. #89901, Thermo Scientific) with protease inhibitors (Halt Protease inhibitor single-use cocktail, Cat.
#78430, Thermo Scientific) on ice, and then lysed by sonication (for 30 seconds on, 30 seconds off, twice at 70% amplitude). Samples were then subjected to constant agitation for 2 hours at 4°C. Lysates were then centrifuged for 20 min at 12,000 rpm at 4°C, and protein-containing supernatants were collected in fresh tubes kept on ice. In samples from fat tissue, an excess of fat Primers (Table S2) were designed using Primer Express software (Applied Biosystems, Carlsbad, CA, USA) and evaluated using LaserGene software (DNAStar, Madison, WI, USA) to ensure either mouse or rat (host)-specificity. Samples were incubated at 95°C for 10 min followed by 40 cycles of 95°C for 15 sec and 60°C for 1 min in an ABI PRISM 7900HT Sequence Detection System (Applied Biosystems). Results were analyzed using the comparative C T (DDC T ) method as described by the manufacturer. Results were analyzed using the comparative C T (∆∆C T ) method and are presented as relative RNA levels compared to the RNA expression in either mock-implanted control cell samples (peripheral intraperitoneal fat tissue, or free floating intraperitoneal lavage cells) after normalization to the β-actin RNA content of each sample. For material spheres alone, we compared everything relative to either 0.3 or 0.5 mm alginate SLG20
spheres. In addition, to further ensure proper normalization and sample handling across multiple retrieval time points, RNA for all samples for each harvest condition (ie., ip lavage, spheres with or without adhered cells and fibrosis, and peripheral tissues with infiltration, as described), were quantified, reverse transcribed, and analyzed by qPCR in parallel. Mouse-specific (host) or rat (islet)-specific forward and reverse primer sets were utilized for this study (Supplemental Table   S2 ).
n. ELISpot multiplexed cytokine analysis
Cytokine array analysis was performed using the assessments where each condition was tested from the same batch of islets (naked islets n = 59; 0.5 mm n = 49; 1.5 mm n = 43).
p. Insulin secretion kinetics
Islet insulin responses were assessed by loading 50 rat islets naked or encapsulated at 0.5 mm and 1.5 mm alginate capsules into the same microfluidic device used for calcium measurements.
Perifusate samples were collected every minute (500 µL/min) by an automated fraction collector 
q. FACS analysis
Single-cell suspensions of freshly excised tissues were prepared using a gentleMACS Dissociator (Miltenyi Biotec, Auburn, CA) according to the manufacturer's protocol. Single-cell suspensions were prepared in a passive PEB dissociation buffer (1X PBS, pH 7.2, 0.5% BSA, and 2 mM EDTA) and suspensions were passed through 70 µm filters (Cat. #22363548, Fisher Scientific, Pittsburgh, PA). This process removed the majority of cells adhered to the surface (>90%) (See Supplemental Figure 17) . All tissue and material sample-derived, single-cell populations were then subjected to red blood cell lysis with 5 ml of 1X RBC lysis buffer (Cat. #00-4333, eBioscience, San Diego, CA, USA) for 5 min at 4 o C. The reaction was terminated by the addition of 20 ml of sterile 1X PBS. The cells remaining were centrifuged at 300-400g at 4°C and resuspended in a minimal volume (~50 µl) of eBioscience Staining Buffer (cat. #00-4222) for antibody incubation. All samples were then co-stained in the dark for 25 min at 4°C
with two of the fluorescently tagged monoclonal antibodies specific for the cell markers CD68 (1 µl (0.5 µg) per sample; CD68-Alexa647, Clone FA-11, Cat. #11-5931, BioLegend), Ly-6G (Gr- 
r. Intravital Imaging and MAFIA depletion
For intravital imaging, SLG20 hydrogels of 0.5 mm and 1.5 mm sizes were loaded with Qdot 605 (Life technologies, Grand Island, NY) and surgically implanted into C57BL/6-Tg(Csf1r-EGFP-NGFR/FKBP1A/TNFRSF6)2Bck/J mice as described above. After 1, 4, or 7 days post implantation, the mice were placed under isoflurane anesthesia and a small incision was made at the site of the original surgery to expose beads. The mice were placed on an inverted microscope and imaged using a 25x, N.A. 1.05 objective on an Olympus FVB-1000 MP multiphoton microscope at an excitation wavelength of 860 nm. Z-stacks of 200 µm (10 µm steps) were acquired at 2-minute intervals for time series of 20 -45 minutes depending on the image. The mice were kept under constant isoflurane anesthesia and monitored throughout the imaging session. Obtained images were analyzed using Velocity 3D Image Analysis Software (Perkin Elmer, Waltham, MA).
In addition, to investigate fibrosis or the lack thereof in control (non-depleted) or induced macrophage-depleted MAFIA mice, 0.5 mm SLG20 spheres were transplanted as described above. In the case of targeted macrophage depletion, an additional group of n = 5 mice were injected intravenously (tail vein) with B/B homodimerizer (Clontech). We achieved significant macrophage depletion (~80-90%, mean group decrease = 84.36%, Supplemental Figure S13c) following our administering of an intravenous injection of 10 mg/kg of the homodimerizer AP20187 in these mice. Repeat depletion in the MAFIA model three days prior and then once every 3 days, starting 3 days following alginate sphere implantation up until retrieval, was able to knock down macrophage numbers far below peritoneal levels observed in the IP space of transplanted, non-depleted control MAFIA mice (~65.26% vs ~10.2%; Supplemental Figure   S13c ).
s. NanoString analysis
RNAs for mock-implanted/mock-treated (MT) controls, or for 0.5 or 1.5 mm alginate spherebearing mice (n = 4/group) were isolated from tissue samples taken at various time points after implantation, as described. Respective RNAs were quantified, diluted to the appropriate concentration (100 ng/µl), and then 500 ng of each sample was processed according to NanoString manufacturer protocols for expression analysis via our customized multiplexed gene mouse macrophage subtyping panel. RNA levels (absolute copy numbers) were obtained following nCounter (NanoString Technologies Inc., Seattle, WA) quantification, and group samples were analyzed using nSolver analysis software (NanoString Technologies Inc., Seattle, WA).
t. Statistical analysis
Data are expressed as mean ± SEM, and N = 5 mice per time point and per treatment group. into sets based on macrophage subtype and compartment. Data was normalized using the geometric means of the NanoString positive controls and background levels were established using the means of the negative controls. Housekeeping genes Tubb5, Hprt1, Bact, and Cltc were used to normalize between samples. Data was then log-transformed. For each subtype, time, and compartment group, a two-way ANOVA for the effect of size blocking on genes was performed.
P-values were computed from pairwise comparisons performed using Tukey's Honest
Significant Difference test and the Bonferroni correction was used to control the overall error rate.
Supplemental Discussion
Diffusion of insulin and glucose as a function of capsule geometry
In beta-cells, glucose-induced insulin secretion is a complex process involving glucose metabolism, mitochondrial energy production, potassium-dependent ATP channels (K ATP channels), voltage-dependent calcium channels (VDCCs), calcium influx, and insulin secretion, which has a biphasic and oscillatory kinetic pattern 5 . In this study, we applied a microfluidic perifusion device to dynamically measure intracellular calcium influx (a downstream and immediately proximal trigger for the fusion of insulin granules to the plasma membrane and exocytosis) and insulin concentrations in perifusate samples in order to characterize the impact of encapsulation and capsule size on insulin secretion coupling factors and insulin secretion. As shown in Supplemental Figure 11A , glucose-induced intracellular calcium signals were similar among the three groups with typical phase responses in all three groups. No significant differences were observed from the start time of calcium influx up to the maximal calcium peak in response to both 20 mM glucose and 30 mM KCl (potassium chloride) challenge. Additionally, the areas under the curve (AUCs) of calcium concentrations under both stimulators were not significantly different (Supplemental Figure 11B) . However, the time to reach the maximal calcium level for the 1.5 mm capsules was statistically delayed in response to glucose compared to the naked islets and 0.5 mm capsules (p = 0.03), but not statistically delayed in response to KCl stimulation.
Our results suggest that small molecules, such as glucose (180.2 daltons) and KCl (74.6 daltons), diffuse very rapidly into the alginate capsules and efficiently induce calcium influx at a similar rate as naked islets. This suggests that the encapsulation process and alginate material do not acutely impede glucose metabolism or insulin stimulator-secretion coupling factors such as mitochondrial energy production and ion channels that are important for in vitro and in vivo function. Furthermore, diffusion efficiency in the capsule may depend on molecular weight of the analyte since there was a delayed time to reach a maximal calcium level in the 1.5 mm capsules in response to glucose (180.2 daltons), but not to KCl (74.6 daltons).
Next, we investigated the insulin secretion kinetics of the naked and encapsulated islets. As shown in Supplemental Figure 12A , naked islets show typical biphasic insulin secretion patterns in response to glucose, while both encapsulated islet groups show loss of the biphasic pattern showing that insulin secretion gradually increases over the period of glucose stimulation without a defined phase I secretion. No significant differences were observed from the start time of insulin secretion up to the maximal peak insulin secretion in response to both 20 mM glucose and 30 mM KCl challenges. However, the times to reach maximal insulin secretion from 20 mM glucose and 30 mM KCl were significantly delayed for 0.5 mm and 1.5 mm encapsulated islets compared to naked islets (p = 0.0002 (20mM glucose), 0.04 (30 mM KCl)). Further analysis of insulin secretory kinetic curves showed that the total insulin secreted by naked islets in the first ten minutes of stimulation was significantly higher than for both 0.5 mm-and 1.5 mmencapsulated islets in responses to both glucose and KCl (p = 0.02 and 0.04, respectively), but not significantly different for later time segments during stimulation. This data further suggests that the larger molecular weight of the insulin (5,808 Da) is the determining factor resulting in longer diffusion time through the alginate gel into the perifusate chamber for both encapsulated groups compared to naked islets.
Total insulin secreted by all groups during stimulation (20-55 min) and during the wash out period after stimulation (55-100 min) was also found not to be significantly different in response to both stimulators (Supplemental Figure 12C and D) . This suggests that overall bulk insulin secretion is unaffected by encapsulation or capsule size. More importantly, encapsulated islets returned to basal insulin secretory levels similar to naked islets, which is a critical factor when considering future clinical application as prolonged insulin secretion after stimulation could cause dangerous hypoglycemia.
Together with normal glucose-induced calcium influx, our results indicate that the altered insulin secretion profiles of the encapsulated islets seem to be largely affected by the presence of an alginate gel due to increasing diffusion time of larger MW insulin from the capsule to the perifusate. This may explain the observed loss of phase I insulin secretion of encapsulated islets in response to glucose. However, there is no significant difference in insulin secretory kinetics between 0.5 mm-and 1.5 mm-encapsulated islets, suggesting capsule size has little effect on insulin secretion.
In summary, islet stimulation kinetics by small molecular weight secretagogues is unaffected by encapsulation or capsule size; however, initial insulin secretory kinetics are delayed similarly for encapsulated islets at both capsule sizes. Nonetheless, overall bulk insulin kinetics for both capsule sizes are well-conserved and similar to naked islets. Tables:   Table S1 . P-values indicating level of significance for comparisons between mock surgeries and implanted SLG20 spheres innate immune responses over time classified by macrophage markers, size, and days after implantation. Nanostring data was log-transformed and a linear model consisting of time, size, gene, compartment, and macrophage type was constructed. Pairwise comparisons between the mock and implanted groups were performed using Tukey's range test.
Supplementary
Significance level α= 0.05. N=4 mice per treatment. For details of analysis see supplemental methods description. Table S2 . Mouse (m) or rat (r)-specific (host) forward and reverse primer sets used for qPCR analysis of RNA levels. Gene names are also shown in parentheses.
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Supplemental Video Legends:
Supplemental Video V1. Laparoscopic video taken during a minimally invasive procedure (at 2 weeks post-implant) for analysis of medium SLG20 spheres delivered into the intraperitoneal space of non-human (cynomolgus macaque) monkeys. Medium (0.5 mm) spheres were almost completely embedded into omental fat tissue, whereas most large (1.5 mm) spheres were free, and often found at the bottom basement of the intraperitoneal cavity (Supplemental Video V2). An IP lavage with saline at 14 days post implantation was unsuccessful at retrieving 0.5 mm sized spheres due to strong adherence and embedding into the IP host tissue (omentum).
Supplemental Video V2. Laparoscopic video taken during a minimally invasive procedure (at 2 weeks post-implant) for analysis of large SLG20 spheres delivered into the intraperitoneal space of non-human (cynomolgus macaque) monkeys. Medium (0.5 mm) spheres were almost completely embedded into omental fat tissue (Supplemental Video V1), whereas most large (1.5 mm) spheres were free, and often found at the bottom basement of the intraperitoneal cavity. An IP lavage with saline at 14 days post implantation enabled significant retrieval of SLG20 1.5 mm capsules.
Supplemental Video V3. In vivo intravital imaging of macrophage behavior and accumulation at 1 day post-implantation to understand kinetics of host response to SLG20 alginate microspheres of 0.5 mm sizes in diameter, confirms significant macrophage activity and numbers around 0.5 mm sized capsules. N = 3 mice per treatment. Intravital imaging experiments were performed twice.
Supplemental Video V4. In vivo intravital imaging of macrophage behavior and accumulation at 1 day post-implantation to understand kinetics of host response to SLG20 alginate microspheres of 1.5 mm sizes in diameter, confirms a lack of macrophage activity and numbers surrounding 1.5 mm size capsules. N = 3 mice per treatment. Intravital imaging experiments were performed twice.
Supplemental Video V5. In vivo intravital imaging of macrophage behavior and accumulation at 4 day post-implantation to understand kinetics of host response to SLG20 alginate microspheres of 0.5 mm sizes in diameter, confirms significant increases and expansion in macrophage activity and numbers around 0.5 mm sized capsules. N = 3 mice per treatment.
Intravital imaging experiments were performed twice.
Supplemental Video V6. In vivo intravital imaging of macrophage behavior and accumulation at 4 day post-implantation to understand kinetics of host response to SLG20 alginate microspheres of 1.5 mm sizes in diameter, confirms a prolonged lack of macrophage activity and numbers surrounding 1.5 mm size capsules. N = 3 mice per treatment. Intravital imaging experiments were performed twice.
Supplemental Video V7. In vivo intravital imaging of macrophage behavior and accumulation at 7 day post-implantation to understand kinetics of host response to SLG20 alginate microspheres of 0.5 mm sizes in diameter, confirms significant and continued increases and expansion in macrophage activity. N = 3 mice per treatment. Intravital imaging experiments were performed twice.
